Integra LifeSciences - 1792 Exchange

Rating Overview

Integra LifeSciences is Medium Risk.

Integra LifeSciences Holdings Corporation is Medium Risk. The company often yields to political activism in shaping corporate governance, potentially alienating consumers, dividing employees, and harming shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. Integra LifeSciences occasionally embraces corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues at times. This approach fails to safeguard free exercise, free speech, and free enterprise.

Rating Criteria

Corporate Weaponization Risk Levels
Criteria	Risk Level
Cancellations	Medium Risk
Discriminatory Philanthropy	High Risk
Employment Protection	High Risk

Corporate Weaponization ⓘ

Corporate Governance and Public Policy Risk Levels
Criteria	Risk Level
Advocacy Bias	High Risk
Funding	Lower Risk
Political Actions	No Data

Corporate Governance and Public Policy ⓘ

Rating Criteria Detail

Criteria Risk Level Rationale

Corporate Weaponization

Criteria:

Has canceled customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.

Risk Level:

Medium

Rationale:

Integra LifeSciences integrates ESG into its business practices. From its 2024 ESG Report: “. In 2024, we made meaningful progress on our ESG roadmap by shifting from financial-focused materiality assessment to
a broader approach that considers not only financial health, but also how our actions impact environmental and social factors.” (1). However, the company has not publicly canceled customers, suppliers, or vendors based on political views or religious beliefs (2).

Criteria:

Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.

Risk Level:

High

Rationale:

Integra LifeSciences will not give to “Political, fraternal, or religious organizations” (1). The company’s charitable giving focus areas are: medical education and needs-based patient support and health educational programs (2).

Criteria:

Employment policies fail to protect against viewpoint or other discrimination and/or are ideological in nature.

Risk Level:

High

Rationale:

In 2023, Integra LifeSciences required its employees to take “The Introduction to Managing Unconscious Bias
course” and “Practicing Inclusion” (1). The company also requires its employees complete annual training on “Inclusion and Diversity” (2). Integra LifeSciences has a history of divisive corporate policies and practices. However, in 2024, the company removed DEI training policies from its 2024 ESG Report. To date, the company has not publicly addressed this change, leaving shareholders without clarity regarding the company’s reasoning or future direction (3). The company appears to prioritize diversity over merit in its leadership composition. From its 2024 ESG Report: “We strive for diversity in our leadership ranks that is representative of our overall population. Through mentorship, sponsorship, recruitment efforts and development programs, we will grow our population of females in leadership roles at Integra” (4). The company does not provide viewpoint protections for its employees (5).

Corporate Governance and Public Policy

Criteria:

Uses corporate reputation to support causes, organizations, or policies hostile to freedom of expression.

Risk Level:

High

Rationale:

Integra LifeSciences’ former CEO, Jan De Witte, signed the CEO Action for Diversity & Inclusion pledge, which includes a commitment to promote DEI through bias education training in the workplace, strategize on DEI programs/initiatives with other signatories, and engage boards of directors when developing and evaluating DEI strategies (1)(2). The company supports ESG within its business practices. From its 2024 ESG Report: “As we continue this journey, we remain dedicated to refining our ESG strategy to drive both business value and positive global impact.” (3). Otherwise, there are no publicly known cases of Integra LifeSciences using its reputation to advance ideological causes or policies (4).

Criteria:

Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.

Risk Level:

Lower

Rationale:

Integra LifeSciences has not used corporate funds to advance ideological causes, organizations, or policies (1).

Criteria:

Uses corporate political actions and/or financial contributions for ideological, non-business purposes.

Risk Level:

N/A

Rationale:

Integra LifeSciences does not operate a PAC or report on its lobbying at this time (1)(2)(3).